PARADIGM-2314
A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction
- Stage
- klaar
- Medicine
- LCZ 696 vs enalapril
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 15 November 2009
- Last Patient In
- 6 November 2012
- Last Patient Last Visit
- -
Study Director
